Despite the restricted expression of CaMKKβ in normal cells, it is overexpressed in several types of cancer compared to adjacent benign tissue (Table 1), including gastric tumours [85], hepatocellular carcinoma [86], high-grade gliomas [87], ovarian [88] and prostate cancer [89,90,91]. This evidence concerns the gene CAMKK2 and central nervous system cancer.